Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.
Lilly, Innovent pen $8.8B oncology, immunology collab that 'moves beyond traditional licensing'
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.